Posts

Latham Advises Financial Team in Coinbase Direct Listing

Coinbase is an American company that operates a cryptocurrency exchange platform. Coinbase is a distributed company; all employees operate via remote work and the company lacks a physical headquarters.

Latham & Watkins represented the financial advisers to cryptocurrency exchange platform Coinbase Global, Inc. in its direct listing on the Nasdaq Global Select Market under the ticker symbol “COIN” on April 14, 2021.

Latham previously represented Spotify in its ground-breaking direct listing on the NYSE in 2018 and the financial advisers in the direct listings of Slack and Asana on the NYSE in 2019 and 2020, respectively.

Latham represented the financial advisers to Coinbase in its direct listing with a capital markets team led by New York partners Marc Jaffe, Greg Rodgers, and Benjamin Cohen, with New York associates Brittany Ruiz, Jonathan Hernandez, and Darby Dietrich.

Advice was provided on corporate matters by Chicago partner Max Schleusener; on financial regulatory and cryptocurrency matters by New York partner Stephen Wink, with London associate Shaun Musuka; on financial regulatory, payments, and AML matters by Washington, D.C. partner Todd Beauchamp and London partner Stuart Davis, with Washington, D.C. associates Charles Weinstein and Loyal Horsley and London associates Gabriel Lakeman, Sam Maxson, and Sidhartha Lal; on bank regulatory matters by New York partner Alan Avery and New York counsel Pia Naib; on FCPA & sanctions matters by Washington, D.C. partner Eric Volkman, with Washington, D.C. associate C.J. Rydberg; on CFTC regulatory, enforcement, and litigation matters by New York partner Yvette Valdez and Chicago partner Eric Swibel, with New York associates Ashley Weeks, Adam Fovent, and Iris Xie; on tax matters by New York partner Jiyeon Lee-Lim, with New York associate Seung Hyun Yang; on benefits and compensation matters by New York partner Bradd Williamson, with New York associate Anne Bracaglia; on data privacy and security matters by Washington, D.C. partner Jennifer Archie, with Washington, D.C. associate James Smith and London partner Fiona Maclean and London counsel Danielle van der Merwe, with London associate Liz Longster.

Multinational Law Firm Advises Bioventus on Initial IPO

An initial IPO is a public offering in which shares of a company are sold to institutional investors and usually also to retail investors. An IPO is typically underwritten by one or more investment banks, who also arrange for the shares to be listed on one or more stock exchanges.

Bioventus Inc. has announced the pricing of its initial public offering of 8 million shares of Class A common stock at a public offering price of US$13 per share.

The Company’s Class A common stock began trading on the Nasdaq Global Select Market under the symbol “BVS.”

Latham & Watkins LLP represents Bioventus, Inc. in the offering with a corporate team led by Boston/New York partner Wesley Holmes and Orange County / New York partner Charles Ruck, with associates Katie Lovejoy, Jessica Lim, Jonathan Hernandez, and Hera Liao.

Bioventus is a global leader of innovations for active healing and surgical orthobiologics with a comprehensive portfolio of clinically efficacious and cost-effective solutions for patients, physicians and payers.

Latham is an American multinational law firm. Founded in 1934 in Los Angeles, California, Latham is the second-largest law firm in the world by revenue. As of 2021, Latham is also one of the most profitable law firms in the world, with profits per partner exceeding US$4.5 million.

Advice was also provided on tax matters by Washington, D.C. partner Andrea Ramezan-Jackson, with associate Eli McCrain; on benefits and compensation matters by New York counsel Rifka Singer, with associate Daniel Gocek; on intellectual property matters by Bay Area partner Judith Hasko, with associate Seth Appiah-Opoku; on public company representation matters by New York partner Dennis Craythorn, with associate Kate Pritchard; on FDA regulatory matters by Washington, D.C. partner Elizabeth Richards, with associate Barrett Tenbarge; and on healthcare regulatory matters by Washington, D.C. partners Stuart Kurlander and Eric Greig.